GlassScriptPhysician profile
Donald J Lauer
NPI 1528076049
$1,209.44
in general payments reported to CMS, 2019-2025
11 companies · $99.20 in 2025
The $99.20 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.13 · 2022: $294 · 2023: $423 · 2024: $378 · 2025: $99.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $899.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $428.16 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $225.37 | 2022-2024 | Andexxa |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2023 | Uptravi, Opsumit |
| Bioxcel Therapeutics, INC. | $121.95 | 2023 | Igalmi |
| Penumbra, INC. | $88.40 | 2024 | Indigo System |
| Fisher & Paykel Healthcare INC | $58.97 | 2023 | Fisher & Paykel Healthcare |
| Kedrion Biopharma, INC. | $54.00 | 2025 | Kedrab, Gammaked, Koate |
| Grifols USA, LLC | $45.20 | 2025 | Hyperrab |
| Abbvie INC. | $34.01 | 2023-2024 | |
| Allergan, INC. | $15.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.25 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Lauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.